maybe CYC isn’t very good at turning “approval to sell” into sales???
…
India is the most populous country in the world and has a growing middle-class. Indians also smoke a lot, I think. India is an odd country to be one of the tiny few not approved to use Technegas.
….
my concern with CYC is that they could be rather shit at execution….
maybe, now they have finally won US approval, some US big pharma will take them over.
….
the other quirky and irritating thing is that the presentation deck they plan to use for today's webinair is virtually identical to the one they released a few weeks ago…
will I be learning anything new if I tune in today to listen?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)